Generate Biomedicines Statistics
NASDAQ: GENBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.54-0.83 (-8.00%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Generate Biomedicines by the numbers
Generate Biomedicines has a market capitalization of $1.23 billion based on 129.10M shares outstanding. With trailing EPS of $-2.49, Generate Biomedicines is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.8% below its 50-day average and 31.5% below its 200-day average.
Average daily trading volume is 1.24M shares, or about $11.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GENB valuation vs. peer median
| Metric | GENB | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.23B | $1.23B | +0% |
| Avg. volume | 1.24M | 1.01M | +22% |
Peer median across 8 companies: SLN, OCUL, MNKD, MLYS, LBRX, AMPH, GHRS, AVLN.
Valuation
- Market cap
- $1.23B
- EPS (TTM)
- $-2.49
- Shares outstanding
- 129.10M
Price and trading
- Previous close
- 10.37
- Open
- 10.06
- Day range
- 9.40 – 10.58
- 52-week range
- 9.40 – 22.67
- Beta
- —
- Volume
- 967.20K
- Average volume
- 1.24M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 1.23B
- Forward Pe
- -3.82
- Eps
- -2.49
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 22.67
- Week52 Low
- 9.40
- Avg Volume
- 1.24M
- Shares Outstanding
- 129.10M
- Ma50
- 13.79
- Ma200
- 13.92
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -57.92%
- Pct From52w Low
- 1.49%